MDLN

SEC source: 0001193125-26-419824 · ownership.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Hux Investment Pte. Ltd.

Disclosed balance after: 69,408,506

F1 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F2 · ownership.nature: These securities are owned directly by Hux Investment Pte. Ltd. ("Hux"). Hux shares the power to vote and the power to dispose of these securities with GIC Special Investments Pte. Ltd. ("GIC SI") and GIC (with Hux and GIC SI, each a "Reporting Person"), both of which are private limited companies incorporated in Singapore. GIC SI is wholly owned by GIC and is the private equity investment arm of GIC. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore's foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities.

SEC source: 0001193125-26-416053 · ownership.xml · nonDerivative · entry 5

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Hux Investment Pte. Ltd.

Disclosed balance after: 77,225,493

F2 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3 · ownership.nature: These securities are owned directly by Hux. Hux shares the power to vote and the power to dispose of these securities with GIC Special Investments Pte. Ltd. ("GIC SI") and GIC (with Hux and GIC SI, each a "Reporting Person"), both of which are private limited companies incorporated in Singapore. GIC SI is wholly owned by GIC and is the private equity investment arm of GIC. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore's foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities.

SEC source: 0001193125-26-416053 · ownership.xml · nonDerivative · entry 4

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,453,806

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-416053 · ownership.xml · nonDerivative · entry 3

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,542,793

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $36.23, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-416053 · ownership.xml · nonDerivative · entry 2

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Hux Investment Pte. Ltd.

Disclosed balance after: 84,408,506

F2 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F3 · ownership.nature: These securities are owned directly by Hux. Hux shares the power to vote and the power to dispose of these securities with GIC Special Investments Pte. Ltd. ("GIC SI") and GIC (with Hux and GIC SI, each a "Reporting Person"), both of which are private limited companies incorporated in Singapore. GIC SI is wholly owned by GIC and is the private equity investment arm of GIC. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore's foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities.

SEC source: 0001193125-26-416053 · ownership.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,231,483

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.30 to $35.70, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-361183 · ownership.xml · derivative · entry 1

Boyle James M · CIK 0002061052 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 764,252

Underlying: Class A Common Stock · 764,252 shares

Expires not disclosed

F1 · kind: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F1 · price: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F1 · derivative.exercise_date: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F2 · derivative.exercise_date: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · derivative.exercise_date: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

F1 · derivative.expiration_date: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F2 · derivative.expiration_date: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · derivative.expiration_date: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

F2 · ownership.nature: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · ownership.nature: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

SEC source: 0001193125-26-361185 · ownership.xml · derivative · entry 1

Miller Stephen L · CIK 0002060964 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 87,667

Underlying: Class A Common Stock · 87,667 shares

Expires not disclosed

F1 · kind: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F1 · price: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F1 · derivative.exercise_date: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F2 · derivative.exercise_date: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · derivative.exercise_date: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

F1 · derivative.expiration_date: Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.

F2 · derivative.expiration_date: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · derivative.expiration_date: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

F2 · ownership.nature: Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.

F3 · ownership.nature: (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.

F4 · ownership.nature: These securities are held by a trust, of which the Reporting Person is a trustee.

SEC source: 0001193125-26-354079 · ownership.xml · nonDerivative · entry 2

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,802,482

F1 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-354079 · ownership.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,902,482

F1 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-343561 · ownership.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,402,482

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $35.72, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-340273 · ownership.xml · nonDerivative · entry 3

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,992,766

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.90, inclusive.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001104659-26-092738 · tm2622619-1_4seq1.xml · derivative · entry 3

Mozart Holdco, Inc. · CIK 0002095472 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,520,656

Underlying: Class A Common Stock · 500,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.

F1 · kind: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

F1 · price: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

F3 · derivative.exercise_date: Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.

F3 · derivative.expiration_date: Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.

SEC source: 0001104659-26-092738 · tm2622619-1_4seq1.xml · nonDerivative · entry 2

Mozart Holdco, Inc. · CIK 0002095472 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,520,656

F1 · kind: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

F2 · shares: Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.

F1 · price: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

F2 · balance_after: Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.

SEC source: 0001104659-26-092738 · tm2622619-1_4seq1.xml · nonDerivative · entry 1

Mozart Holdco, Inc. · CIK 0002095472 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 787,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

F1 · price: Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).

SEC source: 0001193125-26-340273 · ownership.xml · nonDerivative · entry 2

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,264,760

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.72, inclusive.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-340273 · ownership.xml · nonDerivative · entry 1

GIC Private Ltd · CIK 0000936828 · 10% owner

GIC Special Investments Pte Ltd · CIK 0001296212 · 10% owner

Hux Investment Pte. Ltd. · CIK 0002038483 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,530,471

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.99, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

F2 · ownership.direct: Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001193125-26-274287 · ownership.xml · derivative · entry 6

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 365,864

Underlying: Class A Common Stock · 100,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

F2 · derivative.exercise_date: Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

F2 · derivative.expiration_date: Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

F2 · ownership.nature: Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

SEC source: 0001193125-26-274287 · ownership.xml · nonDerivative · entry 5

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 365,864

F6 · kind: Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock were automatically cancelled.

F6 · price: Shares of the Issuer's Class B common stock ("Class B Common Stock") have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon the exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock were automatically cancelled.

SEC source: 0001193125-26-274287 · ownership.xml · nonDerivative · entry 4

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,899

F3 · kind: Reflects sales effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.98 to $37.19 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-274287 · ownership.xml · nonDerivative · entry 3

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,933

F3 · kind: Reflects sales effected pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.98 to $36.9785 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001193125-26-274287 · ownership.xml · nonDerivative · entry 2

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their common units of Medline Holdings, LP ("Common Units") for shares of Medline Inc.'s (the "Issuer") Class A common stock ("Class A Common Stock") on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire. Such Common Units were held indirectly through Medline Management Aggregator LLC.

SEC source: 0001193125-26-274355 · ownership.xml · nonDerivative · entry 1

Abrams William J · CIK 0002061059 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,546

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274342 · ownership.xml · nonDerivative · entry 1

Shryock Christopher P · CIK 0002061070 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,031

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274330 · ownership.xml · nonDerivative · entry 1

Miller Stephen L · CIK 0002060964 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,899

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274323 · ownership.xml · nonDerivative · entry 1

Liberman Alexander M. · CIK 0001460217 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,031

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274310 · ownership.xml · nonDerivative · entry 1

Laabs Amanda H. · CIK 0002061266 · Chief Product Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,899

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274302 · ownership.xml · nonDerivative · entry 1

Drazin Michael B · CIK 0002060967 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,899

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274287 · ownership.xml · nonDerivative · entry 1

Golwas Douglas P · CIK 0002061504 · Chief Commercial Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,899

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-274286 · ownership.xml · nonDerivative · entry 1

Boyle James M · CIK 0002061052 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,369

F1 · kind: Reflects shares withheld to satisfy the Reporting Person's tax liability in connection with the vesting of restricted stock units.

SEC source: 0001193125-26-271377 · ownership.xml · nonDerivative · entry 2

GALANTI RICHARD A · CIK 0001184493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,392

F2 · kind: Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.

SEC source: 0001193125-26-271373 · ownership.xml · nonDerivative · entry 2

Sweet Thomas W · CIK 0001399072 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,387

F3 · kind: Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.

SEC source: 0001193125-26-271363 · ownership.xml · nonDerivative · entry 2

Bluedorn Todd M · CIK 0001395277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,732

F2 · kind: Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.

SEC source: 0001193125-26-263843 · ownership.xml · nonDerivative · entry 1

CORCORAN JESSI L · CIK 0001750376 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 7

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HFCP X (Parallel - A), L.P.

Disclosed balance after: 6,377,698

F4 · kind: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F5 · kind: The recipients of the shares of Class A Common Stock distributed pursuant to footnote 4 have agreed to be subject to a lock-up agreement with the representatives of the several underwriters in connection with the underwritten public offering of the Issuer referred to above, provided that shares constituting less than 1% of the Issuer's outstanding common stock in the aggregate that are being delivered to charitable organizations will not be subject to such restrictions.

F4 · price: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 6

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Hellman & Friedman Capital Partners X (Parallel), L.P.

Disclosed balance after: 61,054,619

F4 · kind: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F5 · kind: The recipients of the shares of Class A Common Stock distributed pursuant to footnote 4 have agreed to be subject to a lock-up agreement with the representatives of the several underwriters in connection with the underwritten public offering of the Issuer referred to above, provided that shares constituting less than 1% of the Issuer's outstanding common stock in the aggregate that are being delivered to charitable organizations will not be subject to such restrictions.

F4 · price: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 5

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mend Investment Holdings I, L.P.

Disclosed balance after: 19,310

F4 · kind: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F5 · kind: The recipients of the shares of Class A Common Stock distributed pursuant to footnote 4 have agreed to be subject to a lock-up agreement with the representatives of the several underwriters in connection with the underwritten public offering of the Issuer referred to above, provided that shares constituting less than 1% of the Issuer's outstanding common stock in the aggregate that are being delivered to charitable organizations will not be subject to such restrictions.

F4 · price: On May 28, 2026, in connection with the sales reported above, each of Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., and Mend Investment Holdings I, L.P. initiated distributions of shares of Class A Common Stock to their respective ultimate partners and shareholders as in-kind distributions in respect of such persons' interests in the distributing entities. The receipt of shares of Class A Common Stock by each of the Reporting Persons in connection with such distributions was exempt from reporting pursuant to Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 4

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By HFCP X (Parallel - A), L.P.

Disclosed balance after: 6,519,062

F1 · price: This amount represents the $37.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.4625 per share sold by the Reporting Persons in connection with an underwritten public offering.

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 3

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Hellman & Friedman Capital Partners X (Parallel), L.P.

Disclosed balance after: 62,591,526

F1 · price: This amount represents the $37.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.4625 per share sold by the Reporting Persons in connection with an underwritten public offering.

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 2

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mend Partners II, L.P.

Disclosed balance after: 3,422,699

F1 · price: This amount represents the $37.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.4625 per share sold by the Reporting Persons in connection with an underwritten public offering.

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251924 · ownership.xml · nonDerivative · entry 1

Hellman & Friedman Capital Partners X (Parallel), L.P. · CIK 0001841430 · 10% owner

HFCP X (Parallel-A), L.P. · CIK 0001841189 · 10% owner

Mend Partners II, L.P. · CIK 0001877047 · 10% owner

Mend Investment Holdings I, L.P. · CIK 0002074968 · 10% owner

Hellman & Friedman Investors X, L.P. · CIK 0001868392 · 10% owner

Mend Partners GP, LLC · CIK 0002074972 · 10% owner

Mend Investment Holdings GP, LLC · CIK 0002074980 · 10% owner

Hellman & Friedman Capital Partners X, L.P. · CIK 0001841434 · 10% owner

H&F Corporate Investors X, Ltd. · CIK 0001901930 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mend Investment Holdings I, L.P.

Disclosed balance after: 228,840

F1 · price: This amount represents the $37.00 secondary public offering price per share of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), less the underwriting discount of $0.4625 per share sold by the Reporting Persons in connection with an underwritten public offering.

F2 · ownership.nature: Hellman & Friedman Investors X, L.P. ("Investors X GP") is the general partner of Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. Mend Partners GP, LLC ("Mend GP") is the general partner of Mend Partners II, L.P. Investors X GP is the managing member of Mend GP. Mend Investment Holdings GP, LLC ("Mend Investment GP") is the general partner of Mend Investment Holdings I, L.P. Hellman & Friedman Capital Partners X, L.P. ("HFCP X") is the managing member of Mend Investment GP. Investors X GP is the general partner of HFCP X. H&F Corporate Investors X, Ltd. ("Investors X Ltd.") is the general partner of Investors X GP.

F3 · ownership.nature: (Continued from footnote 2) A three-member board of directors of Investors X Ltd. has voting and investment discretion over the securities held by Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), Mend Partners II, L.P., and Mend Investment Holdings I, L.P. Each of the members of the board of directors of Investors X Ltd. disclaims beneficial ownership of such shares.

SEC source: 0001193125-26-251894 · ownership.xml · nonDerivative · entry 2

HEALY PATRICK J · CIK 0001182911 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By a family trust

Disclosed balance after: 172,383

F1 · kind: Represents a distribution in kind of shares of the Class A common stock of Medline Inc. ("Class A Common Stock") previously held directly by Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. in relation to the Reporting Person's and a family trust's respective indirect interests in such distributing entities.

F1 · price: Represents a distribution in kind of shares of the Class A common stock of Medline Inc. ("Class A Common Stock") previously held directly by Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. in relation to the Reporting Person's and a family trust's respective indirect interests in such distributing entities.

F2 · ownership.nature: Represents shares of Class A Common Stock beneficially owned indirectly by the Reporting Person through a trust for the benefit of certain of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares of Class A Common Stock held by the trust, except to the extent of his pecuniary interest therein.

SEC source: 0001193125-26-251894 · ownership.xml · nonDerivative · entry 1

HEALY PATRICK J · CIK 0001182911 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,387,921

F1 · kind: Represents a distribution in kind of shares of the Class A common stock of Medline Inc. ("Class A Common Stock") previously held directly by Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. in relation to the Reporting Person's and a family trust's respective indirect interests in such distributing entities.

F1 · price: Represents a distribution in kind of shares of the Class A common stock of Medline Inc. ("Class A Common Stock") previously held directly by Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel - A), L.P. in relation to the Reporting Person's and a family trust's respective indirect interests in such distributing entities.

SEC source: 0001193125-26-251449 · ownership.xml · nonDerivative · entry 5

BX Mozart ML-2 Holdco L.P. · CIK 0002102360 · 10% owner

BX Mozart ML-1 Holdco L.P. · CIK 0002102428 · 10% owner

Mozart Aggregator II UNLV Holdco L.P. · CIK 0002108059 · 10% owner

Mozart Aggregator UNLV Holdco L.P. · CIK 0002108063 · 10% owner

Mozart Aggregator II LP · CIK 0002098582 · 10% owner

BX Mozart ML-2 Holdco GP L.L.C. · CIK 0002102581 · 10% owner

BX Mozart ML-1 Holdco GP L.L.C. · CIK 0002102570 · 10% owner

BCP Mozart Aggregator L.P. · CIK 0002094487 · 10% owner

Blackstone Management Associates VIII L.P. · CIK 0002084378 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,990,467

F9 · kind: On May 28, 2026, Mozart Aggregator II LP initiated in-kind distributions of shares of Class A Common Stock to one of its investors and certain affiliated entities of that investor. Such distributees have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among the Reporting Persons and the underwriters.

F9 · price: On May 28, 2026, Mozart Aggregator II LP initiated in-kind distributions of shares of Class A Common Stock to one of its investors and certain affiliated entities of that investor. Such distributees have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among the Reporting Persons and the underwriters.

F6 · ownership.nature: Reflects shares of Class A Common Stock of the Issuer held directly by Mozart Aggregator II LP. Blackstone Management Associates VIII L.P. is the general partner of Mozart Aggregator II LP. BMA VIII L.L.C. is the general partner of Blackstone Management Associates VIII L.P.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251449 · ownership.xml · nonDerivative · entry 4

BX Mozart ML-2 Holdco L.P. · CIK 0002102360 · 10% owner

BX Mozart ML-1 Holdco L.P. · CIK 0002102428 · 10% owner

Mozart Aggregator II UNLV Holdco L.P. · CIK 0002108059 · 10% owner

Mozart Aggregator UNLV Holdco L.P. · CIK 0002108063 · 10% owner

Mozart Aggregator II LP · CIK 0002098582 · 10% owner

BX Mozart ML-2 Holdco GP L.L.C. · CIK 0002102581 · 10% owner

BX Mozart ML-1 Holdco GP L.L.C. · CIK 0002102570 · 10% owner

BCP Mozart Aggregator L.P. · CIK 0002094487 · 10% owner

Blackstone Management Associates VIII L.P. · CIK 0002084378 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,539

F1 · price: In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $37.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.4625 per share.

F5 · ownership.nature: Reflects securities of the Issuer held directly by Mozart Aggregator UNLV Holdco L.P. BCP 8 Holdings Mozart Manager L.L.C. is the general partner of Mozart Aggregator UNLV Holdco L.P. BMA VIII L.L.C. is the managing member of BCP 8 Holdings Mozart Manager L.L.C.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251449 · ownership.xml · nonDerivative · entry 3

BX Mozart ML-2 Holdco L.P. · CIK 0002102360 · 10% owner

BX Mozart ML-1 Holdco L.P. · CIK 0002102428 · 10% owner

Mozart Aggregator II UNLV Holdco L.P. · CIK 0002108059 · 10% owner

Mozart Aggregator UNLV Holdco L.P. · CIK 0002108063 · 10% owner

Mozart Aggregator II LP · CIK 0002098582 · 10% owner

BX Mozart ML-2 Holdco GP L.L.C. · CIK 0002102581 · 10% owner

BX Mozart ML-1 Holdco GP L.L.C. · CIK 0002102570 · 10% owner

BCP Mozart Aggregator L.P. · CIK 0002094487 · 10% owner

Blackstone Management Associates VIII L.P. · CIK 0002084378 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 10,250,904

F1 · price: In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $37.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.4625 per share.

F4 · ownership.nature: Reflects securities of the Issuer held directly by Mozart Aggregator II UNLV Holdco L.P. Blackstone Management Associates VIII L.P. is the general partner of Mozart Aggregator II UNLV Holdco L.P. BMA VIII L.L.C. is the general partner of Blackstone Management Associates VIII L.P.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251449 · ownership.xml · nonDerivative · entry 2

BX Mozart ML-2 Holdco L.P. · CIK 0002102360 · 10% owner

BX Mozart ML-1 Holdco L.P. · CIK 0002102428 · 10% owner

Mozart Aggregator II UNLV Holdco L.P. · CIK 0002108059 · 10% owner

Mozart Aggregator UNLV Holdco L.P. · CIK 0002108063 · 10% owner

Mozart Aggregator II LP · CIK 0002098582 · 10% owner

BX Mozart ML-2 Holdco GP L.L.C. · CIK 0002102581 · 10% owner

BX Mozart ML-1 Holdco GP L.L.C. · CIK 0002102570 · 10% owner

BCP Mozart Aggregator L.P. · CIK 0002094487 · 10% owner

Blackstone Management Associates VIII L.P. · CIK 0002084378 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 10,185

F1 · price: In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $37.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.4625 per share.

F3 · ownership.nature: Reflects securities of the Issuer held directly by BX Mozart ML-1 Holdco L.P. BX Mozart ML-1 Holdco GP L.L.C. is the general partner of BX Mozart ML-1 Holdco L.P. BCP Mozart Aggregator L.P. is the managing member of BX Mozart ML-1 Holdco GP L.L.C. BCP 8 Holdings Mozart Manager L.L.C. is the general partner of BCP Mozart Aggregator L.P. BMA VIII L.L.C. is the managing member of BCP 8 Holdings Mozart Manager L.L.C.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251449 · ownership.xml · nonDerivative · entry 1

BX Mozart ML-2 Holdco L.P. · CIK 0002102360 · 10% owner

BX Mozart ML-1 Holdco L.P. · CIK 0002102428 · 10% owner

Mozart Aggregator II UNLV Holdco L.P. · CIK 0002108059 · 10% owner

Mozart Aggregator UNLV Holdco L.P. · CIK 0002108063 · 10% owner

Mozart Aggregator II LP · CIK 0002098582 · 10% owner

BX Mozart ML-2 Holdco GP L.L.C. · CIK 0002102581 · 10% owner

BX Mozart ML-1 Holdco GP L.L.C. · CIK 0002102570 · 10% owner

BCP Mozart Aggregator L.P. · CIK 0002094487 · 10% owner

Blackstone Management Associates VIII L.P. · CIK 0002084378 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 89,537,913

F1 · price: In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $37.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.4625 per share.

F2 · ownership.nature: Reflects securities of the Issuer held directly by BX Mozart ML-2 Holdco L.P. BX Mozart ML-2 Holdco GP L.L.C. is the general partner of BX Mozart ML-2 Holdco L.P. Mozart Aggregator II LP is the managing member of BX Mozart ML-2 Holdco GP L.L.C. Blackstone Management Associates VIII L.P. is the general partner of Mozart Aggregator II LP. BMA VIII L.L.C. is the general partner of Blackstone Management Associates VIII L.P.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251451 · ownership.xml · nonDerivative · entry 5

BCP 8 Holdings Mozart Manager L.L.C. · CIK 0002094484 · 10% owner

BMA VIII L.L.C. · CIK 0002084966 · 10% owner

Blackstone Holdings II L.P. · CIK 0001484870 · 10% owner

Blackstone Holdings I/II GP L.L.C. · CIK 0001464695 · 10% owner

Blackstone Inc. · CIK 0001393818 · 10% owner

Blackstone Group Management L.L.C. · CIK 0001404071 · 10% owner

SCHWARZMAN STEPHEN A · CIK 0001070844 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,990,467

F9 · kind: On May 28, 2026, Mozart Aggregator II LP initiated in-kind distributions of shares of Class A Common Stock to one of its investors and certain affiliated entities of that investor. Such distributees have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among the Reporting Persons and the underwriters.

F9 · price: On May 28, 2026, Mozart Aggregator II LP initiated in-kind distributions of shares of Class A Common Stock to one of its investors and certain affiliated entities of that investor. Such distributees have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among the Reporting Persons and the underwriters.

F6 · ownership.nature: Reflects shares of Class A Common Stock of the Issuer held directly by Mozart Aggregator II LP. Blackstone Management Associates VIII L.P. is the general partner of Mozart Aggregator II LP. BMA VIII L.L.C. is the general partner of Blackstone Management Associates VIII L.P.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

SEC source: 0001193125-26-251451 · ownership.xml · nonDerivative · entry 4

BCP 8 Holdings Mozart Manager L.L.C. · CIK 0002094484 · 10% owner

BMA VIII L.L.C. · CIK 0002084966 · 10% owner

Blackstone Holdings II L.P. · CIK 0001484870 · 10% owner

Blackstone Holdings I/II GP L.L.C. · CIK 0001464695 · 10% owner

Blackstone Inc. · CIK 0001393818 · 10% owner

Blackstone Group Management L.L.C. · CIK 0001404071 · 10% owner

SCHWARZMAN STEPHEN A · CIK 0001070844 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,539

F1 · price: In connection with the closing of the secondary offering of Class A common stock ("Class A Common Stock") of Medline Inc. (the "Issuer"), certain of the Reporting Persons sold shares of Class A Common Stock to the underwriters at a price per shares equal to the public offering price of $37.00 per shares of Class A Common Stock, less the underwriting discounts and commissions of $0.4625 per share.

F5 · ownership.nature: Reflects securities of the Issuer held directly by Mozart Aggregator UNLV Holdco L.P. BCP 8 Holdings Mozart Manager L.L.C. is the general partner of Mozart Aggregator UNLV Holdco L.P. BMA VIII L.L.C. is the managing member of BCP 8 Holdings Mozart Manager L.L.C.

F7 · ownership.nature: Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.

F8 · ownership.nature: Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.